Cargando…

4-1BB Signaling Breaks the Tolerance of Maternal CD8(+) T Cells That Are Reactive with Alloantigens

4-1BB (CD137, TNFRSF9), a member of the activation-induced tumor necrosis factor receptor family, is a powerful T-cell costimulatory molecule. It generally enhances CD8(+) T responses and even breaks the tolerance of CD8(+) T cells in an antigen-specific manner. In the present study we found that it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kwang H., Choi, Beom K., Kim, Jung D., Kim, Young H., Lee, Sun K., Suh, Jae H., Lee, Sang C., Kang, Sang W., Kwon, Byoung S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448654/ https://www.ncbi.nlm.nih.gov/pubmed/23029041 http://dx.doi.org/10.1371/journal.pone.0045481

Ejemplares similares

4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8(+) T cell
por: Cho, Eunjung, et al.
Publicado: (2023)

4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8(+) T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling
por: Oh, Ho S., et al.
Publicado: (2015)

Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8(+) T cell responses
por: Kim, Seon-Hee, et al.
Publicado: (2020)

4-1BB Signaling Activates the T Cell Factor 1 Effector/β-Catenin Pathway with Delayed Kinetics via ERK Signaling and Delayed PI3K/AKT Activation to Promote the Proliferation of CD8(+) T Cells
por: Lee, Do Y., et al.
Publicado: (2013)

Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8(+) T Cell Responses
por: Cho, Eunjung, et al.
Publicado: (2023)

CD28 Blockade Ex Vivo Induces Alloantigen-Specific Immune Tolerance but Preserves T-Cell Pathogen Reactivity
por: Dillinger, Barbara, et al.
Publicado: (2017)

Alloantigenic recognition properties of CD8(+) regulatory T cells
por: Picarda, Elodie, et al.
Publicado: (2011)

Detection of Virus-Specific CD8+ T Cells With Cross-Reactivity Against Alloantigens: Potency and Flaws of Present Experimental Methods
por: van den Heuvel, Heleen, et al.
Publicado: (2015)

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
Publicado: (1993)

Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors
por: Eom, Hyeon-Seok, et al.
Publicado: (2016)

Alloantigen persistence in induction and maintenance of transplantation tolerance
Publicado: (1987)

Exposure of a Distinct PDCA-1(+) (CD317) B Cell Population to Agonistic Anti-4-1BB (CD137) Inhibits T and B Cell Responses Both In Vitro and In Vivo
por: Vinay, Dass S., et al.
Publicado: (2012)

Cd4(+)Cd25(+) Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade
por: Taylor, Patricia A., et al.
Publicado: (2001)

Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance
por: Mathew, James M., et al.
Publicado: (2018)

CD99 and the Chicken Alloantigen D Blood System †
por: Fulton, Janet E., et al.
Publicado: (2023)

Proliferation in vivo of T lymphocytes reactive to histocompatibility alloantigens: a correction
Publicado: (1975)

Foxp3(+) Regulatory and Conventional CD4(+) T Cells Display Similarly High Frequencies of Alloantigen-Reactive Cells
por: Lalfer, Mélanie, et al.
Publicado: (2019)

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
por: Davies, Jeff K., et al.
Publicado: (2011)

A machine learning-based quantitative model (LogBB_Pred) to predict the blood–brain barrier permeability (logBB value) of drug compounds
por: Shaker, Bilal, et al.
Publicado: (2023)

4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy
por: Vinay, Dass S., et al.
Publicado: (2014)

Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition
por: Breman, Eytan, et al.
Publicado: (2016)

Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway
Publicado: (1991)

SPONTANEOUS RELEASE OF T-CELL RECEPTORS FOR ALLOANTIGENS : I. RECOGNITION OF ALLOANTIGENS AND RECEPTOR RELEASE DYNAMICS
por: Ramseier, Hansruedy
Publicado: (1974)

Effective clearance of rituximab-resistant tumor cells by breaking the mirror-symmetry of immunoglobulin G and simultaneous binding to CD55 and CD20
por: Lee, Sang Min, et al.
Publicado: (2023)

Higgs to bb in ATLAS
por: Lee, J S H
Publicado: (2013)

4‐1BB Delineates Distinct Activation Status of Exhausted Tumor‐Infiltrating CD8(+) T Cells in Hepatocellular Carcinoma
por: Kim, Hyung‐Don, et al.
Publicado: (2019)

Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα(hi) CD8(+) T cells
por: Kim, Seon-Hee, et al.
Publicado: (2021)

SURFACE ALLOANTIGENS OF PLASMA CELLS
por: Takahashi, Toshitada, et al.
Publicado: (1970)

B-lymphocyte alloantigens in Caucasians
Publicado: (1976)

IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo
por: Sawitzki, Birgit, et al.
Publicado: (2005)

Anti-4-1BB antibody-based combination therapy augments antitumor immunity by enhancing CD11c(+)CD8(+) T cells in renal cell carcinoma
por: Ju, Seong-A, et al.
Publicado: (2022)

Tolerance and autoimmunity to erythroid differentiation (B-G) major histocompatibility complex alloantigens of the chicken
Publicado: (1982)

T cell tolerance to non-H-2-encoded stimulatory alloantigens is induced intrathymically but not prethymically
Publicado: (1983)

CD2 is involved in maintenance and reversal of human alloantigen- specific clonal anergy
Publicado: (1994)

4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39(+) CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
por: Leem, Galam, et al.
Publicado: (2020)

Alloantigen receptors on activated T cells in mice. I. Binding of alloantigens and anti-idiotypic antibodies to the same receptors
Publicado: (1978)

The role of ACAID and CD4(+)CD25(+)FOXP3(+) regulatory T cells on CTL function against MHC alloantigens
por: Saban, Daniel R., et al.
Publicado: (2008)

Ex Vivo Generation of Human Alloantigen-Specific Regulatory T Cells from CD4(pos)CD25(high) T Cells for Immunotherapy
por: Peters, Jorieke H., et al.
Publicado: (2008)

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
por: Alzhrani, Alaa, et al.
Publicado: (2020)

The contribution of mutant amino acids to alloantigenicity
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_jmk5q0ireovik1n07cs5fti3o5